Replies to post #147766 on Biotech Values

[pcrutch]

Maybe we should revisit all of your nonsense posts on PPHM dating back to 2004 and compare with the stock chart. Been an utter disaster and terrible call.

[DewDiligence]

PPHM longs continue to promulgate the canard that accelerated approval in second-line NSCLC possible based on a phase-2 trial that missed its primary endpoint. This has never happened in FDA history, as far as I know.

[Superfly15]

Tell me, how many dollars in sales will the glorified placebo Bavi generate in the next 10 years?


Answer to help you out :: ZERO


Continue to baghold..er I mean invest until your heart is content.